• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中枢神经系统对恶性肿瘤治疗的影响。

CNS effects following the treatment of malignancy.

机构信息

Department of Neuroradiology, The West Wing, John Radcliffe Hospital, Oxford Radcliffe NHS Trust, Oxford, UK.

出版信息

Clin Radiol. 2012 Jan;67(1):61-8. doi: 10.1016/j.crad.2011.01.010. Epub 2011 Nov 3.

DOI:10.1016/j.crad.2011.01.010
PMID:22055261
Abstract

Corporeal and central nervous system (CNS) axis chemotherapy and radiotherapy have long been used for the effective treatment and prophylaxis of CNS, body malignancies, and leukaemias. However, they are not without their problems. Following the proliferation of magnetic resonance neuroimaging in recent years it has become clear that the spectrum of toxicity that these therapies produce ranges from subclinical white matter changes to overt brain necrosis. The effects are both direct and indirect and via different pathological mechanisms. Chronic and progressive changes can be detected many years after the initial intervention. In addition to leucoencephalopathic changes, grey matter changes are now well described. Changes may be difficult to distinguish from tumour recurrence, though may be reversible and remediable, and are thus very important to differentiate. In this review toxic effects are classified and their imaging appearances discussed, with reference to specific syndromes.

摘要

体部和中枢神经系统(CNS)轴化疗和放疗长期以来一直被用于有效治疗和预防 CNS、身体恶性肿瘤和白血病。然而,它们并非没有问题。近年来,随着磁共振神经影像学的普及,人们已经清楚地认识到,这些治疗方法所产生的毒性谱从亚临床的白质变化到明显的脑坏死不等。这些影响既有直接的,也有间接的,通过不同的病理机制。在最初的干预措施之后很多年,都可以检测到慢性和进行性的变化。除了脑白质病变化,现在也很好地描述了灰质变化。这些变化可能难以与肿瘤复发相区分,尽管可能是可逆和可补救的,因此非常重要的是要进行区分。在这篇综述中,我们对毒性作用进行了分类,并讨论了它们的影像学表现,同时参考了特定的综合征。

相似文献

1
CNS effects following the treatment of malignancy.中枢神经系统对恶性肿瘤治疗的影响。
Clin Radiol. 2012 Jan;67(1):61-8. doi: 10.1016/j.crad.2011.01.010. Epub 2011 Nov 3.
2
Long-term cognitive outcome, brain computed tomography scan, and magnetic resonance imaging in children cured for acute lymphoblastic leukemia.急性淋巴细胞白血病治愈儿童的长期认知结局、脑部计算机断层扫描及磁共振成像
Cancer. 2002 Dec 15;95(12):2562-70. doi: 10.1002/cncr.10999.
3
The role of dose escalation with intracavitary brachytherapy in the treatment of localized CNS malignancies: outcomes and toxicities of a prospective study.腔内近距离放射治疗剂量递增在局限性中枢神经系统恶性肿瘤治疗中的作用:一项前瞻性研究的结果与毒性
Brachytherapy. 2010 Jan-Mar;9(1):91-9. doi: 10.1016/j.brachy.2009.06.005. Epub 2009 Oct 21.
4
Cancer therapy-associated CNS neuropathology: an update and review of the literature.癌症治疗相关的中枢神经系统神经病理学:文献综述与更新
Acta Neuropathol. 2006 Mar;111(3):197-212. doi: 10.1007/s00401-005-0023-y. Epub 2006 Feb 4.
5
Integrating imaging findings in evaluating the post-chemotherapy brain.结合影像学表现评估化疗后脑。
Brain Imaging Behav. 2013 Dec;7(4):436-52. doi: 10.1007/s11682-013-9239-y.
6
Regarding: Rosenthal DI, Glatstein E. "We've Got a Treatment, but What's the Disease?" The Oncologist 1996;1.关于:罗森塔尔·迪、格拉茨坦·埃。《我们有了一种治疗方法,但疾病是什么?》,《肿瘤学家》1996年;第1期。
Oncologist. 1997;2(1):59-61.
7
Diffusion-weighted MR of the brain: methodology and clinical application.脑部扩散加权磁共振成像:方法与临床应用
Radiol Med. 2005 Mar;109(3):155-97.
8
Delayed effects of whole brain radiotherapy in germ cell tumor patients with central nervous system metastases.全脑放疗对中枢神经系统转移的生殖细胞肿瘤患者的延迟效应。
Int J Radiat Oncol Biol Phys. 2008 Apr 1;70(5):1361-4. doi: 10.1016/j.ijrobp.2007.11.005.
9
[Visualization of radiation effects on the central nervous system].[辐射对中枢神经系统影响的可视化]
Radiologe. 2012 Mar;52(3):229-34. doi: 10.1007/s00117-011-2197-8.
10
Delayed complications of radiotherapy treatment for nasopharyngeal carcinoma: imaging findings.鼻咽癌放射治疗的延迟并发症:影像学表现
Clin Radiol. 2007 Mar;62(3):195-203. doi: 10.1016/j.crad.2006.10.011.

引用本文的文献

1
Applying Tissue Slice Culture in Cancer Research-Insights from Preclinical Proton Radiotherapy.组织切片培养在癌症研究中的应用——来自临床前质子放疗的见解
Cancers (Basel). 2020 Jun 16;12(6):1589. doi: 10.3390/cancers12061589.
2
Initial Investigation into Microbleeds and White Matter Signal Changes following Radiotherapy for Low-Grade and Benign Brain Tumors Using Ultra-High-Field MRI Techniques.使用超高场 MRI 技术对低级别和良性脑肿瘤放疗后微出血和白质信号变化的初步研究。
AJNR Am J Neuroradiol. 2017 Dec;38(12):2251-2256. doi: 10.3174/ajnr.A5395. Epub 2017 Sep 28.
3
Targeting human oligodendrocyte progenitors for myelin repair.
靶向人类少突胶质前体细胞进行髓鞘修复。
Exp Neurol. 2016 Sep;283(Pt B):489-500. doi: 10.1016/j.expneurol.2016.03.017. Epub 2016 Mar 18.
4
Radiation-Induced Alteration of the Brain Proteome: Understanding the Role of the Sirtuin 2 Deacetylase in a Murine Model.辐射诱导的脑蛋白质组改变:在小鼠模型中了解沉默调节蛋白2去乙酰化酶的作用
J Proteome Res. 2015 Oct 2;14(10):4104-17. doi: 10.1021/acs.jproteome.5b00083. Epub 2015 Sep 16.
5
Late new morbidity in survivors of adolescent and young-adulthood brain tumors in Finland: a registry-based study.芬兰青少年和青年期脑肿瘤幸存者的晚期新发疾病:一项基于登记处的研究。
Neuro Oncol. 2015 Oct;17(10):1412-8. doi: 10.1093/neuonc/nov115. Epub 2015 Jul 1.
6
Evolution of multidisciplinary brain metastasis management: case study and literature review.多学科脑转移瘤管理的进展:病例研究与文献综述
Yale J Biol Med. 2015 Jun 1;88(2):157-65. eCollection 2015 Jun.
7
Delayed contrast extravasation MRI: a new paradigm in neuro-oncology.延迟对比剂外渗磁共振成像:神经肿瘤学的新范式。
Neuro Oncol. 2015 Mar;17(3):457-65. doi: 10.1093/neuonc/nou230. Epub 2014 Nov 30.
8
Postradiation imaging changes in the CNS: how can we differentiate between treatment effect and disease progression?中枢神经系统放疗后的影像学改变:我们如何区分治疗效果和疾病进展?
Future Oncol. 2014 May;10(7):1277-97. doi: 10.2217/fon.13.271.
9
Delayed contrast extravasation MRI for depicting tumor and non-tumoral tissues in primary and metastatic brain tumors.磁共振对比剂渗出延迟成像在原发性和转移性脑肿瘤中对肿瘤及非肿瘤组织的描绘
PLoS One. 2012;7(12):e52008. doi: 10.1371/journal.pone.0052008. Epub 2012 Dec 14.
10
Normal tissue protection for improving radiotherapy: Where are the Gaps?改善放射治疗的正常组织保护:差距在哪里?
Transl Cancer Res. 2012 Jun;1(1):35-48.